How an Activist Group Helped Torpedo MDMA Therapy
Posted inClinical Trials Drugs (Pharmaceuticals) Ethics and Official Misconduct Food and Drug Administration Institute for Clinical and Economic Review Lykos Therapeutics Mental Health and Disorders Multidisciplinary Assn for Psychedelic Studies Post-Traumatic Stress Disorder Psychedelic and Hallucinogenic Drugs Psychiatry and Psychiatrists Psymposia Regulation and Deregulation of Industry Research Therapy and Rehabilitation Veterans

How an Activist Group Helped Torpedo MDMA Therapy

The fallout from the F.D.A.’s rejection of a new treatment for PTSD worries researchers and experts who fear other psychedelic drugs in the pipeline could be jeopardized.
‘LIfe-Changing’ Psychedelic, for When Life Is Ending
Posted inCancer Cancer (Journal) Death and Dying Depression (Mental) Drugs (Pharmaceuticals) Food and Drug Administration Hospice Care Journal of Psychopharmacology Ketamine (Drug) Oregon Post-Traumatic Stress Disorder Psilocybin Mushrooms Psychedelic and Hallucinogenic Drugs Psychiatry and Psychiatrists Regulation and Deregulation of Industry Research Veterans Veterans Affairs Department

‘LIfe-Changing’ Psychedelic, for When Life Is Ending

People are turning to psilocybin, ketamine and other treatments for palliative care.